[1]
“The Crossroad between Intellectual Property and Clinical Trials: Balancing Incentives for Innovation with Access to Healthcare”, Trend. Intellect. Prop. Res., vol. 1, no. 2, Oct. 2024, doi: 10.69971/tipr.1.2.2023.16.